Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
about
Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care HospitalCarbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and PreventionCase-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infectionsCarbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance studyManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance MethodsCarbapenem-Resistant Enterobacteriaceae Infections in Children.KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniaeCarbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014.Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile.Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.Risk factors for the acquisition of OXA-48-producing Enterobacteriaceae in a hospital outbreak setting: a matched case-control study.Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes.Act Fast as Time Is Less: High Faecal Carriage of Carbapenem-Resistant Enterobacteriaceae in Critical Care Patients.Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients.The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms.Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department.Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement.Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.Multidrug-resistant bacteria in organ transplantation: an emerging threat with limited therapeutic options.Provider Role in Transmission of Carbapenem-Resistant Enterobacteriaceae.Carbapenem-resistant Enterobacter cloacae isolates producing KPC-3, North Dakota, USA.Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.
P2860
Q28550029-65B832E9-9F3A-44F9-B615-F1046C508374Q30148824-AE0728E0-302C-4233-A588-C51657336436Q30458327-B3DE1B75-9AC8-4777-8E76-E840E9CC05CEQ34298840-7D07FADD-1AA5-4760-956C-38B1BA900E5CQ34437229-71656678-35E1-4BF2-90B9-ED9BD4A7FB65Q35250361-52157D63-5E4F-459D-868B-EBC6DB6C9CB4Q36078359-E0CA7BA2-02B2-48DB-82F3-7B500EA37C0CQ36260443-4BB0EFCF-664D-42C7-A925-D08F48EA1C35Q36297599-E915FBC5-991B-45D6-A408-0B4E32A96603Q36631019-CBEE1354-60A2-4800-B394-81EB9D29B719Q37154718-B40FBA3B-8621-416A-A1D2-9E3724F6F833Q37280606-B2CA47E2-4BE7-4F01-A988-0BFCFEE93057Q37484822-B7935E5D-4974-49EA-97BD-B93A6F333D80Q37700038-58B1EA2B-432E-4F3E-9E68-A49EDB3ED119Q38152302-AD4AEA18-7DFC-4DCD-9809-3B052B4D0AF7Q38199187-48A3094D-6CC9-4511-93D8-14A83BB115DFQ38286351-73146A92-9DF4-4AF9-BC4B-3F52C3833018Q38624963-659E6F70-1F81-43FC-B138-EA189F564F2BQ38845084-92CDBA74-68FA-48E9-B115-9FC152058EDDQ38868953-00D8D19B-148E-491F-900B-9BCCC991270AQ38875303-F7F41F25-C7D1-43FA-8308-F80B659D28C8Q38934524-2CAEEF8F-47EB-43B6-A13F-D601ED78BE8FQ39240563-F6A4CC55-011F-46C7-A382-0373E50A9631Q39796166-D268F837-81AB-4466-8B53-CA08C0AD9351Q40159951-663B25C2-AF45-403A-9C98-BB69F9310E6DQ40175800-C88F2052-402C-4844-8670-900FA78F9177Q40256554-33F00BDD-A084-45CE-AE3E-DD6DFBEECB7AQ40303856-204A3EA8-F2CE-426D-9543-EBB34436F81EQ40311528-5C30A11E-1051-43F3-AD34-9D5EC6C7E79CQ40375426-6B5E8257-A712-4D58-B6A7-E928EA82F1ADQ40495898-531266DE-80AB-4936-8653-4829DB3CEDCEQ40578460-E4B14424-1657-46A7-8732-F781B83017FAQ40601745-02C1765E-CD7F-4CD3-A79F-F018B64E036BQ41724140-5531A523-15B7-42DB-A55E-747D56434E1BQ41991759-6B4BC952-8D3E-49D7-B1CB-285DFA8FA2A8Q42245248-F3CE311F-74F2-4DA9-92CF-D9EFC3387080Q42698389-320AE54A-6DA7-493E-9E9F-2E4441C40875Q42920008-5A5CED13-AD93-416A-9220-55FE42DCDBF2Q43173786-DABFD644-CAD5-45A5-A7B7-BA201F77E4F5Q46291390-B819867A-8350-4D7A-80C2-C23BE4AB22D3
P2860
Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prevalence and risk factors fo ...... in the setting of endemicity.
@en
type
label
Prevalence and risk factors fo ...... in the setting of endemicity.
@en
prefLabel
Prevalence and risk factors fo ...... in the setting of endemicity.
@en
P2093
P2860
P356
P1476
Prevalence and risk factors fo ...... in the setting of endemicity.
@en
P2093
Arjun Srinivasan
Brandon Kitchel
David B Banach
David P Calfee
Gopi Patel
Karen F Anderson
Mahesh Swaminathan
Saarika Sharma
Stephanie Poliansky Blash
Vincent LaBombardi
P2860
P304
P356
10.1086/671270
P577
2013-06-11T00:00:00Z